Medexus Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:P731 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Feb 24	Buy€3,721	Benoit Gravel	Individual	3,200	€1.16
30 Jun 23	Buy€90,541	Stephen Nelson	Individual	93,800	€0.97
29 Jun 23	Buy€4,400	Kenneth d'Entremont	Individual	3,800	€1.16
23 Jun 23	Buy€6,986	Michael Mueller	Individual	7,000	€1.00
23 Jun 23	Buy€14,819	Kenneth d'Entremont	Individual	15,000	€0.99
23 Jun 23	Buy€4,874	Marcel Konrad	Individual	5,100	€0.96

Insider Buying: P731 insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.2%.

Top 15 shareholders own 22.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.28%	Armistice Capital LLC	1,536,000	€2.0m	-35.2%	0.06%
5.98%	Kenneth d'Entremont	1,461,869	€1.9m	0%	no data
4.25%	GoodWood Inc.	1,038,716	€1.4m	0%	39.98%
2.24%	Stephen Nelson	547,079	€718.5k	0%	no data
1.77%	Lumira Ventures	432,063	€567.4k	0%	1.0%
0.55%	Perritt Capital Management, Inc.	135,100	€177.4k	0%	0.1%
0.37%	Michael Mueller	89,870	€118.0k	0%	no data
0.33%	Marcel Konrad	80,021	€105.1k	0%	no data
0.23%	Benoit Gravel	56,358	€74.0k	6.02%	no data
0.12%	Michael Adelman	28,800	€37.8k	0%	no data
0.084%	Ian Wildgoose Brown	20,634	€27.1k	0%	no data
0.081%	Richard Labelle	19,847	€26.1k	0%	no data
0.054%	Menassie Taddese	13,259	€17.4k	0%	no data
0.054%	Harmony Garges	13,259	€17.4k	0%	no data
0.0068%	The Michael and Carol Mueller Family Foundation, Endowment Arm	1,667	€2.2k	0%	100.0%